To play devils advocate here. Anyone have thoughts on what effect unsuccessful ph2 trials would have on the future of Neuren? Would Acadia still take us out? Share price doesn't look to have ph2 baked in. Would we see big pullbacks initially? Would we have to explore other possible areas for treatment?
a.
To play devils advocate here. Anyone have thoughts on what...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.02 |
Change
-1.250(6.17%) |
Mkt cap ! $2.428B | |||
| Open | High | Low | Value | Volume |
| $20.40 | $20.50 | $18.82 | $19.92M | 1.034M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1652 | $19.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.03 | 11612 | 4 |
View Market Depth
| Last trade - 16.10pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.10 |
Change
-1.250 ( 6.19 %) |
||||
| Open | High | Low | Volume | ||
| $20.39 | $20.46 | $18.83 | 299764 | ||
| Last updated 15.59pm 04/06/2024 ? | |||||
| NEU (ASX) Chart |